XCEL-MC-ALPHA

N/A

Report date: 2023/01/12 15:28:33

Base Information

Drug NameXCEL-MC-ALPHA

Drug Alias NameBone-marrow mesenchymal stromal cellsXCEL-MC-ALPHA

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic ProgressiveMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesBanc De Sang I Teixits

China Registration ClassN/A

Develop Information

Active CompaniesBanc De Sang I Teixits

Inactive CompaniesN/A

Active IndicationsMultiple Sclerosis

Inactive IndicationsMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic Progressive

Other Information

ATC CodeN/A